Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026)
Cytosorbents (CTSO) posted Current Deferred Revenue of $1.14 million for Q2 2026, up 215.5% from $361,000 a year earlier.
Powered by 
Analysis
Cytosorbents (CTSO) Current Deferred Revenue (2013 - 2026) Analysis & Trends
At the end of FY2025, Cytosorbents' Current Deferred Revenue came in at $182,000, down 69.5% from FY2024.
- Annual Current Deferred Revenue has declined for four consecutive years, with a five-year compound annual growth rate of -24.2% (FY2020 to FY2025).
- In prior years, Cytosorbents' Current Deferred Revenue was $596,000 in FY2024 (-56.8%), $1.38 million in FY2023 (-9.0%), $1.52 million in FY2022 (-22.1%) and $1.95 million in FY2021 (+167.4%).
- The Q2 2026 figure stands as the highest quarterly Current Deferred Revenue since Q4 2023.
- On a year-over-year basis, Current Deferred Revenue increased in 1 of the last four quarters, with an average decline of 1.1%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $34,000 (Q1 2026), $182,000 (Q4 2025) and $403,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 251.30 Bn | 230.45 Bn | 4.88 Bn |
| 2 | Abbott Laboratories | 174.70 Bn | 145.78 Bn | 7.27 Bn |
| 3 | Danaher | 158.94 Bn | 142.76 Bn | 3.61 Bn |
| 4 | Intuitive Surgical | 145.87 Bn | 125.42 Bn | 1.96 Bn |
| 5 | Medtronic | 111.49 Bn | 77.36 Bn | 6.34 Bn |
| 6 | Stryker | 106.96 Bn | 93.08 Bn | 4.50 Bn |
| 7 | Boston Scientific | 63.62 Bn | 58.63 Bn | 3.85 Bn |
| 8 | Edwards Lifesciences | 50.80 Bn | 34.92 Bn | 1.35 Bn |
| 9 | Becton Dickinson | 49.59 Bn | 46.74 Bn | 2.32 Bn |
| 10 | Cytosorbents | 12.57 Mn | -10.44 Mn | 7.05 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.14 Mn |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 182,000.00 |
| Sep 30, 2025 | 403,000.00 |
| Jun 30, 2025 | 361,000.00 |
| Mar 31, 2025 | 546,028.00 |
| Dec 31, 2024 | 596,000.00 |
| Dec 31, 2023 | 1.38 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2021 | 1.95 Mn |
| Dec 31, 2020 | 728,351.00 |
| Dec 31, 2014 | 833.00 |
| Sep 30, 2014 | 3,333.00 |
| Jun 30, 2014 | 5,833.00 |
| Mar 31, 2014 | 117,364.00 |
| Dec 31, 2013 | 272,359.00 |
| Sep 30, 2013 | 435,686.00 |
API Access
Cytosorbents Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTSO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "CTSO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=CTSO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();